Charlie Hall is Polygon’s tabletop editor. In 12-plus years as a journalist & photographer, he has covered simulation, strategy, and spacefaring games, as well as public policy. Several elements ...

The D&D 2024 Monster Manual is the final piece of the 2024 Core Rulebooks – including the Dungeon Master's Guide and Player Handbook. With it not only can DMs craft intricate worlds and players create ...

Akero Therapeutics has hit a home run, reporting statistically significant results in two key 96-week metabolic dysfunction-associated steatohepatitis (MASH) analyses to send its stock up about 100%.

After 96 weeks, 39% of patients offered a 50-mg dose of efruxifermin showed a clinically meaningful reduction in liver fibrosis, or scarring, without other symptoms of MASH getting worse ...

Shares of Akero ascended by 115% in early Monday trading upon the news. MASH-associated cirrhosis patients “face a poor prognosis,” Catriona Yale, chief development officer at Akero, said on an ...

Monster Beverage (NASDAQ:MNST) maintained its momentum Thursday after climbing 1.71% the previous day, following an investor event in New York City where the company highlighted its 2025 ...